Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.73
+0.12 (2.14%)
At close: Mar 12, 2025, 4:00 PM
5.72
-0.01 (-0.26%)
After-hours: Mar 12, 2025, 4:18 PM EST
Solid Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 12, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 444 | 160 | 124 | 105 | 193 | 499 | |
| Market Cap Growth | 29.00% | 29.00% | 17.92% | -45.57% | -61.33% | 143.92% | |
| Enterprise Value | 315 | 13 | 8 | -11 | -34 | 480 | |
| Last Close Price | 5.61 | 4.00 | 6.14 | 5.38 | 26.25 | 113.70 | |
| PS Ratio | - | - | - | 12.98 | 14.17 | - | |
| PB Ratio | 1.65 | 1.16 | 0.98 | 0.50 | 0.93 | 3.78 | |
| P/TBV Ratio | 1.16 | 1.16 | 0.98 | 0.50 | 0.93 | 3.78 | |
| Debt / Equity Ratio | 0.18 | 0.18 | 0.21 | 0.13 | 0.01 | 0.04 | |
| Asset Turnover | - | - | - | 0.03 | 0.07 | - | |
| Quick Ratio | 4.92 | 4.92 | 8.52 | 9.50 | 8.81 | 6.32 | |
| Current Ratio | 5.20 | 5.20 | 8.94 | 9.76 | 9.43 | 6.49 | |
| Return on Equity (ROE) | -94.57% | -94.57% | -56.79% | -40.96% | -42.43% | -83.24% | |
| Return on Assets (ROA) | -45.86% | -45.86% | -30.67% | -23.95% | -22.38% | -39.35% | |
| Return on Capital (ROIC) | -51.62% | -51.62% | -33.18% | -26.19% | -25.99% | -48.17% | |
| Earnings Yield | -28.33% | -78.02% | -77.50% | -81.84% | -37.40% | -17.69% | |
| FCF Yield | -22.87% | -62.99% | -77.24% | -96.13% | -40.95% | -11.52% | |
| Buyback Yield / Dilution | -105.27% | -105.27% | -133.60% | -19.58% | -105.58% | -28.91% | |
| Total Shareholder Return | -105.27% | -105.27% | -133.60% | -19.58% | -105.58% | -28.91% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.